| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.064 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |